Sana Biotechnology, Inc. - SANA

Sector: Healthcare · Industry: Biological Products, (No Diagnostic Substances)
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q1 2026 · Q4 2025
Value (USD)
Total reported value ($000)
$518.6M
QoQ value delta ($000)
-$132.4M (-20.34%)
Implied price effect (QoQ)
-27.5%
Shares
Total shares
175,560,608
QoQ shares delta
+15,765,476 (+9.87%)
Total shares held by funds (by quarter)

Market chart (SANA)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q1 2026)

Top 25 only Full list
Partial Q1 2026 data: 202 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
Manager Value ($000) Shares % of 13F
FMR LLC 107,799 37,430,284 0.01%
Flagship Pioneering, LLC 72,005 25,001,856 6.2%
VANGUARD GROUP INC 42,552 10,455,195 0.0%
BlackRock, Inc. 41,011 14,240,175 0.0%
STATE STREET CORP 30,349 10,538,086 0.0%
CANADA PENSION PLAN INVESTMENT BOARD 29,439 10,221,900 0.02%
VANGUARD CAPITAL MANAGEMENT LLC 21,412 7,434,724 0.0%
BAILLIE GIFFORD & CO 19,034 6,609,065 0.02%
GEODE CAPITAL MANAGEMENT, LLC 12,046 4,181,973 0.0%
Marex Group plc 11,517 3,999,100 0.07%
Integral Health Asset Management, LLC 9,216 3,200,000 0.44%
GOLDMAN SACHS GROUP INC 9,161 3,181,115 0.0%
BANK OF AMERICA CORP /DE/ 8,486 2,946,861 0.0%
Alphabet Inc. 8,100 2,812,500 0.2%
VANGUARD PORTFOLIO MANAGEMENT LLC 4,917 1,707,521 0.0%
MILLENNIUM MANAGEMENT LLC 4,582 1,591,030 0.0%
NORTHERN TRUST CORP 4,259 1,478,851 0.0%
MORGAN STANLEY 4,204 1,460,015 0.0%
RENAISSANCE TECHNOLOGIES LLC 4,179 1,451,200 0.01%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 3,934 1,366,148 0.0%
UBS Group AG 3,903 1,355,289 0.0%
Woodline Partners LP 3,795 1,317,932 0.01%
TWO SIGMA INVESTMENTS, LP 3,451 1,198,579 0.0%
AQR CAPITAL MANAGEMENT LLC 3,237 1,124,279 0.0%
VANGUARD FIDUCIARY TRUST CO 3,063 1,063,649 0.0%